The price of new innovation for the treatment of multiple myeloma
Why global collaborations are key in multiple myeloma
Myeloma UK as a driver of collaboration between industry and academia
The rationale behind the Myeloma UK Clinical Trial Network
The importance of multiple myeloma foundations and a patient story
Paul Richardson et al.